| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
183.92(B) |
| Last
Volume: |
8,283,468 |
Avg
Vol: |
5,628,682 |
| 52
Week Range: |
$90.19 - $120.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 249 |
| Guru Rank Value : 4.7 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of health care products. Co.'s segments are: Established Pharmaceutical Products, which includes a line of generic pharmaceuticals; Diagnostic Products, which includes a line of diagnostic systems and tests; Nutritional Products, which includes a line of pediatric and adult nutritional products; Medical Devices, which includes a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
32,949 |
92,408 |
217,808 |
559,855 |
| Total Sell Value |
$3,483,938 |
$10,293,581 |
$23,396,593 |
$59,595,311 |
| Total People Sold |
2 |
8 |
9 |
19 |
| Total Sell Transactions |
2 |
10 |
14 |
39 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fussell Stephen R |
Executive Vice President |
• – – |
2017-01-31 |
4 |
B |
$40.77 |
$497,394 |
D/D |
12,200 |
167,167 |
2.74 |
- |
|
| Fain Eric S |
Senior Vice President |
• – – |
2017-01-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
114,240 |
116,333 |
|
- |
|
| Fain Eric S |
Senior Vice PresidentOfficer |
• – – |
2017-01-04 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,093 |
|
- |
|
| Fain Eric S |
Senior Vice PresidentOfficer |
• – – |
2017-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,500 |
|
- |
|
| Fain Eric S |
Senior Vice President |
• – – |
2017-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
519,467 |
520,968 |
|
- |
|
| Rousseau Michael T |
Pres., Cardiovasc. & Neuromod. |
• – – |
2017-01-04 |
4 |
A |
$0.00 |
$0 |
I/I |
446,178 |
632,581 |
|
- |
|
| Rousseau Michael T |
Pres., Cardiovasc. & Neuromod. |
• – – |
2017-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
186,404 |
186,403 |
|
- |
|
| Warmuth Michael J |
Executive Vice President |
• – – |
2017-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15 |
42,874 |
|
- |
|
| Blaser Brian J |
Executive Vice President |
• – – |
2016-12-20 |
4 |
B |
$38.43 |
$599,120 |
D/D |
15,580 |
145,062 |
2.74 |
- |
|
| Ford Robert B |
Executive Vice President |
• – – |
2016-12-14 |
4 |
B |
$39.08 |
$499,345 |
I/I |
12,775 |
69,542 |
1.99 |
- |
|
| Ford Robert B |
Executive Vice President |
• – – |
2016-12-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,804 |
56,767 |
|
- |
|
| Ford Robert B |
Executive Vice President |
• – – |
2016-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,804 |
51,532 |
|
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,380 |
9,512 |
|
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-12-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,020 |
0 |
|
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,040 |
3,109,927 |
|
- |
|
| Capek John M |
Executive Vice President |
• – – |
2016-11-16 |
4 |
OE |
$24.38 |
$536,386 |
D/D |
22,000 |
274,524 |
|
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
B |
$40.39 |
$2,103,455 |
D/D |
51,892 |
2,793,909 |
2.81 |
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
B |
$40.44 |
$1,982,079 |
D/D |
48,761 |
3,053,704 |
2.81 |
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
B |
$40.45 |
$2,369,448 |
D/D |
58,263 |
3,111,967 |
2.81 |
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
B |
$40.38 |
$3,630,294 |
D/D |
89,578 |
3,004,943 |
2.81 |
- |
|
| White Miles D |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
B |
$40.35 |
$4,912,741 |
D/D |
121,456 |
2,915,365 |
2.81 |
- |
|
| Blount Sally E. |
Director |
– • – |
2016-11-01 |
4 |
B |
$39.24 |
$200,124 |
D/D |
5,100 |
20,143 |
2.39 |
- |
|
| Salvadori Daniel Gesua Sive |
Senior Vice President |
• – – |
2016-09-26 |
4 |
S |
$41.71 |
$33,994 |
D/D |
(815) |
58,976 |
|
- |
|
| Salvadori Daniel Gesua Sive |
Senior Vice President |
• – – |
2016-09-26 |
4 |
D |
$42.19 |
$84,422 |
D/D |
(2,001) |
59,791 |
|
- |
|
| Warmuth Michael J |
Executive Vice President |
• – – |
2016-08-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,827 |
39,413 |
|
- |
|
1232 Records found
|
|
Page 39 of 50 |
|
|
0.74 (0.71%) 
